Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 4/2018

25.08.2018 | Neurogenic Bladder (Charles Powell, S. Editor)

Prevalence and Cost of Catheters to Manage Neurogenic Bladder

verfasst von: Devin N. Patel, Christopher Gonzalez Alabastro, Jennifer T. Anger

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In this review, we examine the current literature to address the epidemiology of catheters for managing neurogenic bladder. We will address the epidemiology of conditions associated with neurogenic bladder, including multiple sclerosis, spinal cord injury, Parkinson’s disease, stroke, and spina bifida. Rates of utilization of various catheter strategies, including indwelling urethral catheter, suprapubic catheter, and intermittent catheterization rates will be reviewed. Lastly, we examine the cost considerations between and within each type of strategy.

Recent Findings

Management strategies for neurogenic bladder have evolved overtime. Costs between catheter strategies are largely driven by complications. The highest cost variation within each strategy is related to the technique and type of intermittent catheter. Recently, there has been an increase in costlier single-use intermittent catheter strategies. However, the short- and long-term benefits of these strategies remained understudied.

Summary

Without comparative studies highlighting improvements in complication rates and compliance, the benefits of single-use catheters for intermittent catheterization are largely theoretical. Until such studies are performed, providers should strongly consider managing neurogenic bladder patients with reusable intermittent catheters in order to provide the most cost-conscious care.
Literatur
1.
Ramagopalan SV, Sadovnick AD. Epidemiology of multiple sclerosis. Neurol Clin. 2011;29(2):207–17.PubMedCrossRef
2.
Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9(5):520–32.PubMedCrossRef
3.
DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs. 2003;63(2):153–66.PubMedCrossRef
4.
McGuire EJ, Savastano JA. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction. J Urol. 1984;132(4):713–5.PubMedCrossRef
5.
Wintner A, Kim MM, Bechis SK, Kreydin EI. Voiding dysfunction in multiple sclerosis. Semin Neurol. 2016;36(1):34–40.PubMed
6.
Betts CD, D’Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993;56(3):245–50.PubMedPubMedCentralCrossRef
7.
McKinley WO, Jackson AB, Cardenas DD, DeVivo MJ. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil. 1999;80(11):1402–10.PubMedCrossRef
8.
Lasfargues JE, Custis D, Morrone F, Carswell J, Nguyen T. A model for estimating spinal cord injury prevalence in the United States. Paraplegia. 1995;33(2):62–8.PubMed
9.
Burney RE, Maio RF, Maynard F, Karunas R. Incidence, characteristics, and outcome of spinal cord injury at trauma centers in North America. Arch Surg. 1993;128(5):596–9.PubMedCrossRef
10.
Manack A, Motsko SP, Haag-Molkenteller C, Dmochowski RR, Goehring EL Jr, Nguyen-Khoa BA, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn. 2011;30(3):395–401.
11.
Ginsberg D. The epidemiology and pathophysiology of neurogenic bladder. Am J Manag Care. 2013;19(10 Suppl):s191–6.PubMed
12.
Kaplan SA, Chancellor MB, Blaivas JG. Bladder and sphincter behavior in patients with spinal cord lesions. J Urol. 1991;146(1):113–7.PubMedCrossRef
13.
Weld KJ, Dmochowski RR. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology. 2000;55(4):490–4.PubMedCrossRef
14.
15.
Jankovic J, Sherer T. The future of research in Parkinson disease. JAMA Neurol. 2014;71(11):1351–2.PubMedCrossRef
16.
Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.PubMedCrossRef
17.
Calabrese VP. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;69(2):223–224; author reply 4.
18.
Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, et al. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol. 2008;54(3):563–9.
19.
Araki I, Kitahara M, Oida T, Kuno S. Voiding dysfunction and Parkinson’s disease: urodynamic abnormalities and urinary symptoms. J Urol. 2000;164(5):1640–3.PubMedCrossRef
20.
Unger CA, Tunitsky-Bitton E, Muffly T, Barber MD. Neuroanatomy, neurophysiology, and dysfunction of the female lower urinary tract: a review. Female Pelvic Med Reconstr Surg. 2014;20(2):65–75.PubMedCrossRef
21.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.
22.
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–54.
23.
Nakayama H, Jorgensen HS, Pedersen PM, Raaschou HO, Olsen TS. Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke. 1997;28(1):58–62.PubMedCrossRef
24.
Badlani G. Urologic problems in cerebrovascular accidents. Probl Urol. 1993;41
25.
Khan Z, Starer P, Yang WC, Bhola A. Analysis of voiding disorders in patients with cerebrovascular accidents. Urology. 1990;35(3):265–70.PubMedCrossRef
26.
Centers for Disease C, Prevention. Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995-2005. MMWR Morb Mortal Wkly Rep. 2009;57(53):1409–13.
27.
Shin M, Besser LM, Siffel C, Kucik JE, Shaw GM, Lu C, et al. Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics. 2010;126(2):274–9.
28.
Marshall DF, Boston VE. Does the absence of anal reflexes guarantee a “safe bladder” in children with spina bifida? Eur J Pediatr Surg. 2001;11(Suppl 1):S21–3.PubMedCrossRef
29.
30.
Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 2017;197(2S):S122–S4.PubMedCrossRef
31.
Consortium for Spinal Cord M. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med. 2006;29(5):527–73.
32.
Abrams P, Agarwal M, Drake M, El-Masri W, Fulford S, Reid S, et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int. 2008;101(8):989–94.PubMedCrossRef
33.
Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56(1):81–8.PubMedCrossRef
34.
Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ. Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol. 2010;184(1):213–7.PubMedCrossRef
35.
Afsar SI, Yemisci OU, Cosar SN, Cetin N. Compliance with clean intermittent catheterization in spinal cord injury patients: a long-term follow-up study. Spinal Cord. 2013;51(8):645–9.PubMedCrossRef
36.
Yavuzer G, Gok H, Tuncer S, Soygur T, Arikan N, Arasil T. Compliance with bladder management in spinal cord injury patients. Spinal Cord. 2000;38(12):762–5.PubMedCrossRef
37.
Bellucci CH, Castro Filho JE, Gomes CM, Bessa Junior J, Battistella LR, Souza DR, et al. Contemporary trends in the epidemiology of traumatic spinal cord injury: changes in age and etiology. Neuroepidemiology. 2015;44(2):85–90.PubMedCrossRef
38.
Nijendijk JH, Post MW, van Asbeck FW. Epidemiology of traumatic spinal cord injuries in the Netherlands in 2010. Spinal Cord. 2014;52(4):258–63.PubMedCrossRef
39.
• Krebs J, Wollner J, Pannek J. Bladder management in individuals with chronic neurogenic lower urinary tract dysfunction. Spinal Cord. 2016;54(8):609–13. This reference provided an updated epidemiology of bladder management patterns with respect to type of neurologic dysfunction. Rates of catheterization technique were examined in a large heterogenous population of chronic neurogenic bladder patients. Individuals at risk of indwelling catheterization were identified based on female gender, age, injury severity and injury duration.PubMedCrossRef
40.
Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 2002;83(3):346–51.PubMedCrossRef
41.
Esclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol. 2000;164(4):1285–9.PubMedCrossRef
42.
Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil. 1995;76(3):272–80.PubMedCrossRef
43.
Larsen LD, Chamberlin DA, Khonsari F, Ahlering TE. Retrospective analysis of urologic complications in male patients with spinal cord injury managed with and without indwelling urinary catheters. Urology. 1997;50(3):418–22.PubMedCrossRef
44.
Hollingsworth JM, Rogers MA, Krein SL, Hickner A, Kuhn L, Cheng A, et al. Determining the noninfectious complications of indwelling urethral catheters: a systematic review and meta-analysis. Ann Intern Med. 2013;159(6):401–10.PubMedCrossRef
45.
Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509–15.PubMedCrossRef
46.
Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000;28(1):68–75.PubMedCrossRef
47.
Gift TL, Owens CJ. The direct medical cost of epididymitis and orchitis: evidence from a study of insurance claims. Sex Transm Dis. 2006;33(10 Suppl):S84–8.PubMedCrossRef
48.
Perrouin-Verbe B, Labat JJ, Richard I, Mauduyt de la Greve I, Buzelin JM, Mathe JF. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia. 1995;33(11):619–24.PubMed
49.
Santucci RA, Joyce GF, Wise M. Male urethral stricture disease. J Urol. 2007;177(5):1667–74.PubMedCrossRef
50.
Ord J, Lunn D, Reynard J. Bladder management and risk of bladder stone formation in spinal cord injured patients. J Urol. 2003;170(5):1734–7.PubMedCrossRef
51.
Jamison J, Maguire S, McCann J. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochrane Database Syst Rev. 2013;11:CD004375.
52.
Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol. 2000;163(3):768–72.PubMedCrossRef
53.
Willson M, Wilde M, Webb ML, Thompson D, Parker D, Harwood J, et al. Nursing interventions to reduce the risk of catheter-associated urinary tract infection: part 2: staff education, monitoring, and care techniques. J Wound Ostomy Continence Nurs. 2009;36(2):137–54.
54.
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625–63.
55.
Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. 1998;105(3):236–41.PubMedCrossRef
56.
Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med. 2000;160(17):2670–5.PubMedCrossRef
57.
Jahn P, Preuss M, Kernig A, Seifert-Huhmer A, Langer G. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev. 2007;3:CD004997.
58.
Talja M, Korpela A, Jarvi K. Comparison of urethral reaction to full silicone, hydrogen-coated and siliconised latex catheters. Br J Urol. 1990;66(6):652–7.PubMedCrossRef
59.
Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012;380(9857):1927–35.
60.
Hackler RH. Long-term suprapubic cystostomy drainage in spinal cord injury patients. Br J Urol. 1982;54(2):120–1.PubMedCrossRef
61.
Feifer A, Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn. 2008;27(6):475–9.PubMedCrossRef
62.
MacDiarmid SA, Arnold EP, Palmer NB, Anthony A. Management of spinal cord injured patients by indwelling suprapubic catheterization. J Urol. 1995;154(2 Pt 1):492–4.PubMedCrossRef
63.
O’Brien WM. Percutaneous placement of a suprapubic tube with peel away sheath introducer. J Urol. 1991;145(5):1015–6.PubMedCrossRef
64.
Flock WD, Litvak AS, McRoberts JW. Evaluation of closed suprapubic cystostomy. Urology. 1978;11(1):40–2.PubMedCrossRef
65.
Lance L. Goetz L Droste, Adam P. Klausner and Diane K. Newman. Catheters used for intermittent catheterization. In: Springer, editor. Clinical application of urologic catheters, devices and products 2018. p. 44–77.
66.
Bermingham SL, Hodgkinson S, Wright S, Hayter E, Spinks J, Pellowe C. Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis. BMJ. 2013;346:e8639.PubMedPubMedCentralCrossRef
67.
Silbar EC, Cicmanec JF, Burke BM, Bracken RB. Microwave sterilization: a method for home sterilization of urinary catheters. J Urol. 1989;141(1):88–90.PubMedCrossRef
68.
Bogaert GA, Goeman L, de Ridder D, Wevers M, Ivens J, Schuermans A. The physical and antimicrobial effects of microwave heating and alcohol immersion on catheters that are reused for clean intermittent catheterisation. Eur Urol. 2004;46(5):641–6.PubMedCrossRef
69.
Goetz LL, Klausner AP. Strategies for prevention of urinary tract infections in neurogenic bladder dysfunction. Phys Med Rehabil Clin N Am 2014;25(3):605–618, viii.
70.
Lavallee DJ, Lapierre NM, Henwood PK, Pivik JR, Best M, Springthorpe VS, et al. Catheter cleaning for re-use in intermittent catheterization: new light on an old problem. SCI Nurs. 1995;12(1):10–2.
71.
Kurtz MJ, Van Zandt K, Burns JL. Comparison study of home catheter cleaning methods. Rehabil Nurs 1995;20(4):212–214, 7.
72.
Lamin E, Newman DK. Clean intermittent catheterization revisited. Int Urol Nephrol. 2016;48(6):931–9.PubMedCrossRef
73.
•• Prieto JA, Murphy C, Moore KN, Fader MJ. Intermittent catheterisation for long-term bladder management (abridged cochrane review). Neurourol Urodyn. 2015;34(7):648–53. These recent references revisited the debate between the merits of single-use catheters that were made in a recent Cochrane review article. By reanalyzing Cochrane review data, (after data correction), no difference was found between single- versus multiple-use of catheters with respect to UTI–53.
74.
•• Christison K, Walter M, Wyndaele JJM, Kennelly M, Kessler TM, Noonan VK, et al. Intermittent catheterization: the devil is in the details. J Neurotrauma. 2018; These recent references revisited the debate between the merits of single-use catheters that were made in a recent Cochrane review article. By reanalyzing Cochrane review data, (after data correction), no difference was found between single- versus multiple-use of catheters with respect to UTI.
75.
De Ridder DJ, Everaert K, Fernandez LG, Valero JV, Duran AB, Abrisqueta ML, et al. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial. Eur Urol. 2005;48(6):991–5.PubMedCrossRef
76.
Hudson E, Murahata RI. The ‘no-touch’ method of intermittent urinary catheter insertion: can it reduce the risk of bacteria entering the bladder? Spinal Cord. 2005;43(10):611–4.PubMedCrossRef
77.
Mandal AK, Vaidyanathan S. Management of urethral stricture in patients practising clean intermittent catheterization. Int Urol Nephrol. 1993;25(4):395–9.PubMed
78.
Waller L, Telander M, Sullivan L. The importance of osmolality in hydrophilic urethral catheters: a crossover study. Spinal Cord. 1997;35(4):229–33.PubMedCrossRef
79.
Vaidyanathan S, Soni BM, Dundas S, Krishnan KR. Urethral cytology in spinal cord injury patients performing intermittent catheterisation. Paraplegia. 1994;32(7):493–500.PubMed
80.
Oh SJ, Ku JH, Jeon HG, Shin HI, Paik NJ, Yoo T. Health-related quality of life of patients using clean intermittent catheterization for neurogenic bladder secondary to spinal cord injury. Urology. 2005;65(2):306–10.PubMedCrossRef
81.
Hagen EM, Rekand T. Management of bladder dysfunction and satisfaction of life after spinal cord injury in Norway. J Spinal Cord Med. 2014;37(3):310–6.PubMedPubMedCentralCrossRef
82.
KC Moore ML, Robinson E, Bagulay N, Pearce I. Cleaning and re-using intermittent self catheters: a questionnaire to gauge patient’s perceptions and prejudices. J Clin Urol. 2014;7(4):277–82.CrossRef
Metadaten
Titel
Prevalence and Cost of Catheters to Manage Neurogenic Bladder
verfasst von
Devin N. Patel
Christopher Gonzalez Alabastro
Jennifer T. Anger
Publikationsdatum
25.08.2018
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 4/2018
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-018-0483-2

Weitere Artikel der Ausgabe 4/2018

Current Bladder Dysfunction Reports 4/2018 Zur Ausgabe

Stress Incontinence and Prolapse (S Reynolds, Section Editor)

Is There Still a Role for Transvaginal Mesh in Treatment of Pelvic Organ Prolapse?

Reconstructed Bladder Function and Dysfunction (M Kaufman, Section Editor)

Tibial Nerve and Sacral Neuromodulation in the Elderly Patient

Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Neurogenic Bladder: Recurrent Urinary Tract Infections—Beyond Antibiotics

Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Management of Mesh-Related Pelvic Inflammation

Stress Incontinence and Prolapse (S Reynolds, Section Editor)

Current Update on Management of Male Stress Urinary Incontinence

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Optimizing Postoperative Pain Management in Pelvic Floor Surgery

Neu im Fachgebiet Urologie

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise